Laitinen 1979.
Methods | Crossover design; 1st phase 3 weeks, 2nd phase 2 weeks. | |
Participants | ||
Interventions | Ipratropium bromide 80µg and salbutamol 400µg; both interventions q.i.d. | |
Outcomes | ||
Notes | This comparison not analysed, so details not extracted. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Unclear risk | Information not available (Cochrane Grade B) |